The Effects of Midazolam on the Quality of Postoperative Recovery
NCT ID: NCT01993459
Last Updated: 2016-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
192 participants
INTERVENTIONAL
2014-02-28
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Midazolam Premedication on Copeptine Concentration in Blood
NCT03474939
Does Midazolam Affect Postoperative Pain?
NCT03499730
Midazolam Effect on Agitation Postnasal Surgery
NCT05165914
Assessing the Effectiveness of Midazolam Premedication
NCT03325335
Does Midazolam Cause Effective Anterograde Amnesia in Orthopedic Surgeries?
NCT04232150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Midazolam intravenous
3mg/ml midazolam given intravenously
Midazolam
We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery
NaCl (sodium chloride) 0,9%
NaCl (sodium chloride) 0,9% given intravenously 3ml.
NaCl (sodium chloride) 0,9%
We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Midazolam
We will administer Midazolam 3mg intravenously once pre-operatively to patients just before they undergo surgery
NaCl (sodium chloride) 0,9%
We will administer NaCl (sodium chloride) 0,9% 3ml intravenously once pre-operatively to patients just before they undergo surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasmus Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stefan van Beek
BSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Jan Stolker, MD, PhD
Role: STUDY_CHAIR
Erasmus MC Rotterdam Anesthesiology
Markus Klimek, MD, PhD
Role: STUDY_CHAIR
Erasmus MC Rotterdam Anesthesiology
Stefan van Beek, BSc
Role: PRINCIPAL_INVESTIGATOR
Erasmus MC Rotterdam Anesthesiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasmus Medical Centre
Rotterdam, South Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
van Beek S, Kroon J, Rijs K, Mijderwijk HJ, Klimek M, Stolker RJ. The effect of midazolam as premedication on the quality of postoperative recovery after laparotomy: a randomized clinical trial. Can J Anaesth. 2020 Jan;67(1):32-41. doi: 10.1007/s12630-019-01494-6. Epub 2019 Oct 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14091991
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.